𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Leucoytapheresis with Adacolumn® enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1

✍ Scribed by Helmut M. Diepolder; Nobuhito Kashiwagi; Gerlinde Teuber; Axel Ulsenheimer; Marita Franz; Takashi Yokoyama; Reinhart Zachoval

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
198 KB
Volume
77
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Virus-specific T-cell responses associat
Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection
✍ Juan A. Quiroga; Silvia Llorente; Inmaculada Castillo; Elena Rodríguez-Iñigo; Ju 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

## Abstract Hepatitis C virus (HCV) RNA persistence in the liver has been described even after apparent resolution of HCV infection. Because T‐cell reactivity plays a role in recovery from HCV infection, virus‐specific T‐cell responses were investigated in apparently recovered individuals in whom h

Virus-specific effector CD4+ T-cell resp
Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection
✍ Miguel A. Rico; Sara Ruiz; Dolores Subirá; Guillermina Barril; Secundino Cigarrá 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

Patients with chronic renal failure undergoing hemodialysis who are infected with hepatitis C virus (HCV) may test consistently anti-HCV negative. Because CD4(+) T-cells provide help for antibody production virus-specific effector CD4(+) T-cell responses were investigated in relation to anti-HCV pos

IL28B alleles associated with poor hepat
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
✍ Pierre-Yves Bochud; Stéphanie Bibert; Zoltán Kutalik; Etienne Patin; Julien Guer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

Poynard owns stock in Biopredictive. He also consults for and is on the speakers' bureau of Merck. Dr. Pol consults for, advises, and is on the speakers' bureau of Boehringer Ingleheim, Abbott, and GlaxoSmithKline. He consults for, advises, is on the speakers' bureau of, and received grants from Roc

Genetic characterization of hypervariabl
Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2
✍ Xiaofeng Fan; Adrian M. Di Bisceglie 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

## Abstract The hypervariable region 1 (HVR1) has been most reliably identified in the genome of HCV genotype 1 isolates and thought to possibly play a role in immune evasion and development of chronic infection. There are few studies, however, of other HCV genotypes to determine if they also have

Mutations in the NS5A gene of hepatitis
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
✍ Hofgärtner, Wolfgang T.; Polyak, Stephen J.; Sullivan, Daniel G.; Carithers, Rob 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 3 views

Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [

IL28B genetic variation and treatment re
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
✍ Amir Moghaddam; Espen Melum; Nils Reinton; Helmer Ring-Larsen; Hans Verbaan; Kri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

Polymorphisms near the IL28B gene, which code for interferon (IFN)-λ3, predict response to pegylated interferon-α (PEG-IFN) and ribavirin treatment in hepatitis C virus (HCV) genotype 1 infected patients. Follow-up studies of the effect of IL28B gene in HCV non-genotype 1 infected patients have almo